XML 65 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements Of Cash Flows (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities    
Net loss $ (3,135,581)us-gaap_NetIncomeLoss $ (4,139,848)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 70,256us-gaap_Depreciation 136,663us-gaap_Depreciation
Amortization of intangibles 74,959us-gaap_AmortizationOfIntangibleAssets 74,958us-gaap_AmortizationOfIntangibleAssets
Amortization of deferred finance costs 55,793us-gaap_AmortizationOfFinancingCostsAndDiscounts 70,122us-gaap_AmortizationOfFinancingCostsAndDiscounts
Share-based compensation 326,444us-gaap_ShareBasedCompensation 307,992us-gaap_ShareBasedCompensation
Adjustment of warrants 892,377us-gaap_DerivativeGainLossOnDerivativeNet 1,076,139us-gaap_DerivativeGainLossOnDerivativeNet
Changes in operating assets and liabilities:    
Accounts receivable (1,256,119)us-gaap_IncreaseDecreaseInAccountsReceivable (768,628)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (4,179)us-gaap_IncreaseDecreaseInInventories (694,085)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets 92,225us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (53,993)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Other assets 35,983us-gaap_IncreaseDecreaseInOtherOperatingAssets (62)us-gaap_IncreaseDecreaseInOtherOperatingAssets
Accounts payable 250,495us-gaap_IncreaseDecreaseInAccountsPayable (357,303)us-gaap_IncreaseDecreaseInAccountsPayable
Accrued liabilities (263,221)us-gaap_IncreaseDecreaseInAccruedLiabilities 725,025us-gaap_IncreaseDecreaseInAccruedLiabilities
Deferred revenue (352,450)us-gaap_IncreaseDecreaseInDeferredRevenue 1,244,840us-gaap_IncreaseDecreaseInDeferredRevenue
Other liabilities (75,682)us-gaap_IncreaseDecreaseInOtherOperatingLiabilities  
Net cash used in operating activities (3,288,700)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (2,378,180)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities    
Purchase of equipment (52,410)us-gaap_PaymentsToAcquireMachineryAndEquipment   
Net cash used in investing activities (52,410)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations   
Cash flows from financing activities    
Payments of Healthcare Royalty Partners debt (68,869)us-gaap_RepaymentsOfSecuredDebt (38,592)us-gaap_RepaymentsOfSecuredDebt
Proceeds from issuance of stock, net of issuance costs 578,211stxs_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts (56,514)stxs_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
Net cash provided (used) by financing activities 509,342us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (95,106)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase (decrease) in cash and cash equivalents (2,831,768)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (2,473,286)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of period 7,270,301us-gaap_CashAndCashEquivalentsAtCarryingValue 13,775,130us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of period $ 4,438,533us-gaap_CashAndCashEquivalentsAtCarryingValue $ 11,301,844us-gaap_CashAndCashEquivalentsAtCarryingValue